共 50 条
- [32] The clinical spectrum and G516T CYP2B6 single-nucleotide polymorphism in efavirenz drug-induced liver injury SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2018, 108 (08): : 692 - 692
- [34] High prevalence of the CYP2B6 516G→T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe European Journal of Clinical Pharmacology, 2008, 64 : 357 - 365
- [36] The Effect of UGT 1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 13 - 27
- [38] CYP2B6 516 G>T polymorphism and side effects of the central nervous system in HIVpositive individuals under Efavirenz treatment: Study of a sample from southern Brazil ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2017, 89 (01): : 497 - 504
- [40] GENETIC VARIABILITY OF CYP2B6 G516T AND THEIR IMPACT IN EFAVIRENZ BASED HAART: A META-ANALYSIS INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (03): : 763 - 772